Login
- Title:
[Adjuvant study of high-risk muscle invasive urothelial carcinoma : Open-label, multicenter, randomized phase III study with atezolizumab (anti-PD-L1 antibody) as adjuvant therapy compared with observation in patients with high-risk muscle invasive urothe
- Document type:
- Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Editorial Material
- Author(s):
- Rexer, H; Retz, M; Albers, P
- Journal title abbreviation:
- Urologe A
- Year:
- 2016
- Journal volume:
- 55
- Journal issue:
- 11
- Pages contribution:
- 1491-1493
- Language:
- de
- Fulltext / DOI:
- doi:10.1007/s00120-016-0248-5
- Pubmed ID:
- http://view.ncbi.nlm.nih.gov/pubmed/27714413
- Print-ISSN:
- 0340-2592
- TUM Institution:
- Urologische Klinik und Poliklinik
BibTeX